|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Adial Pharmaceuticals (NASDAQ: ADIL) through any online brokerage.
The latest price target for Adial Pharmaceuticals (NASDAQ: ADIL) was reported by Brookline Capital on October 13, 2021. The analyst firm set a price target for 12.00 expecting ADIL to rise to within 12 months (a possible 244.83% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Adial Pharmaceuticals (NASDAQ: ADIL) is $3.48 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Adial Pharmaceuticals.
Adial Pharmaceuticals’s $Q3 earnings are confirmed for after-market on $November 12, 2021.
There is no upcoming split for Adial Pharmaceuticals.
Adial Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.